ICD-10-CM Billable Code

H11.053

Peripheral pterygium, progressive, bilateral

Clinical Classification Guidelines

Medical Intelligence & Overview

Peripheral pterygium is a benign, non-cancerous growth that develops on the conjunctiva, the clear tissue covering the white part of the eye. When it is described as progressive and bilateral, it indicates that the condition gradually worsens over time and affects both eyes. This condition can influence a person’s vision and ocular comfort if left unmanaged. While it is generally not serious, understanding its nature and management options is important for maintaining eye health.

Causes & Symptoms

Clinical Causes: Excessive exposure to sunlight and ultraviolet (UV) radiation Chronic eye irritation from dust, wind, or pollution Genetic predisposition in some individuals Environmental factors contributing to conjunctival changes

Key Symptoms: Gradual growth of a fleshy, pinkish tissue on the conjunctiva near the cornea Raised, thickened tissue that extends onto the corneal surface Burning sensation or eye irritation Redness and inflammation around the affected area Possible visual disturbances if the growth encroaches on the cornea Typically bilateral, affecting both eyes progressively over time

Diagnostic & Treatment

Diagnosis Path: Diagnosis of peripheral pterygium involves a thorough eye examination by an eye care professional. The clinician will examine the conjunctiva and cornea, noting the size, location, and appearance of the growth. Slit-lamp microscopy helps in assessing the extent of tissue involvement. Additional tests are usually not necessary but may include careful measurement of the growth's progression over time to monitor changes. No laboratory tests are typically required for diagnosis.

Treatment Protocols: Management of peripheral pterygium depends on its size, growth rate, and effects on vision or comfort. Common approaches include: - Observation: Small, asymptomatic pterygia may simply be monitored regularly. - Medical treatment: Use of lubricating eye drops or anti-inflammatory medications can alleviate symptoms but do not prevent growth. - Surgical removal: Indicated if the pterygium causes significant visual impairment, discomfort, or cosmetic concerns. Surgery involves excision of the growth, often with adjunct procedures to reduce recurrence. - Postoperative care: Includes anti-inflammatory eye drops and follow-up visits to monitor healing and prevent recurrence. Prevention strategies stress protecting eyes from UV radiation through sunglasses and hats, reducing exposure to irritants, and wearing protective eyewear in harsh environments.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H11.053 a billable ICD-10 code?
Yes, H11.053 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H11.053?
Clinical documentation must specify the nature of Peripheral pterygium, progressive, bilateral and any associated comorbidities for accurate reporting.

Cite this Clinical Reference